Bio-Techne (NASDAQ: TECH) reported Q2 EPS of $0.88, $0.06 better than the analyst estimate of $0.82. Revenue for the quarter came in at $120.9 million versus the consensus estimate of $118.59 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.